A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
This study is testing how well a medicine called AXS-05 works compared to another medicine called bupropion in stopping depression from coming back. People who join will first take AXS-05 for 10 weeks. If they feel better, they will then be randomly chosen to keep taking AXS-05 or switch to bupropion for 26 weeks, all without knowing which one they're taking.
- **Study Length**: Up to 36 weeks total.
- **Visits Needed**: Multiple visits for monitoring.
- **Eligibility**: Must have a depression diagnosis and can't have used similar medicines recently.
AXS-05 is an experimental medicine, meaning it is still being studied and is not yet widely available. Bupropion is a medicine sometimes used to treat depression. Major Depressive Disorder (MDD) is a condition where someone feels very sad or hopeless for a long time. Participants should not have used similar medicines or been in studies with AXS-05 recently. The study ensures safety and monitors any changes in health closely. 🌟
Study details
NCT06223880
Axsome Therapeutics, Inc.
8 July 2024
Not finding the right Trial?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
FAQs
Learn more about clinical trials
What is a clinical trial?
Why should I take part in a clinical trial?
How long does a clinical trial take place?
Do I get compensated for taking part in clinical trials?
How safe are clinical trials?
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.